NCT03598998 2025-06-26Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell LymphomasCity of Hope Medical CenterPhase 1/2 Active not recruiting13 enrolled 12 charts
NCT01336933 2023-09-22Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin LymphomaUniversity of NebraskaPhase 2 Completed34 enrolled 12 charts